IDIOPATHIC HYPERSOMNIA

Clinical trials for IDIOPATHIC HYPERSOMNIA explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC HYPERSOMNIA trials appear

Sign up with your email to follow new studies for IDIOPATHIC HYPERSOMNIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 1 Not yet finished but already full! 1 Completed 4

New dosing options for xywav could help fight daytime sleepiness

Symptom relief Not yet recruiting

This Phase 3 study tests whether expanded dosing regimens of Xywav can safely reduce excessive daytime sleepiness in adults with narcolepsy or idiopathic hypersomnia. About 108 participants will receive either Xywav or a placebo in a randomized withdrawal design. The main goal is…

Matched conditions: IDIOPATHIC HYPERSOMNIA

Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief

Last updated Jun 27, 2026 13:04 UTC

IDIOPATHIC HYPERSOMNIA

Get alerted when new IDIOPATHIC HYPERSOMNIA trials appear

New dosing options for xywav could help fight daytime sleepiness